You will receive an e-mail with instructions to reset your password

Newborn

Early detection of genetic diseases that appear in the early years of life.

Newborn analysis provides information for preventive treatment, diet or early treatment of genetic diseases that appear during the early stages of life. Knowing this information is key, as 65% of diseases are treatable by diet or by an early approach, before symptoms appear.
icon
9,4%
Up to 9.4% of newborns

may have genetic variations related to childhood-onset diseases.(1)

icon
100%
The test can be performed on any newborn

who has no symptoms of illness, as part of his or her medical care.

icon
390
This analysis complements the biochemical heel prick test,

increasing the number of diseases detected to 390 and increasing clinical utility.

icon
407
Analysis detects variants in 407 genes

related to metabolic and genetic diseases that appear in the first years of life.

Newborn
  • Accurately detects more than 390 diseases that can affect the newborn early in life
  • Identifies variants in 407 genes related to metabolic and genetic diseases that appear in the first years of life.
  • You will receive a vídeo follow-up before and after the analysis by a genetic counsellor listed by medmesafe.
icono de tiempo 4-6 weeks
icono de mundo Spain
icono de la muestra Saliva
icono de genes Whole Exome Secuencing
icono de tiempo
  • Counting from the reception of the sample in the laboratory (Shipping costs included in Spain).
icono de mundo
  • Spain
icono de la muestra
  • Collection of saliva.
icono de genes
  • Whole exome sequencing (WES) with illumina platform (HiSeq X10, NovaSeq 6000).
  • Average coverage 110x sequencing >97% at ≥20x achieving a 300x average coverage in the genes of the panel.
  • CLIA-certifed laboratory (CLIA #22D2089381).
  • CAP accreditation (College of American Pathologists).
  • All the reports are reviewed by an expert medical team with more than 10 years of experience in Whole Genome and Exome sequencing, including members of the Personal Genome Project of Harvard Medical School.
  • Possible Outcomes:
    • Pathogenic variants and probably pathogenic variants are reported
    • The only recessive conditions reported are those with impact on newborn health, the rest are not reported.
    • Secondary findings on genes not included on the panel are not reported.
The service includes the detection of the following types of pathologies:
  • The highly actionable ones of appearance during childhood.
  • Those included in the neonatal biochemical test (heel prick test).
  • Those that appear in adulthood but in which it is possible to be treated during childhood.
  • The common ones, although they are not treatable, with a carrier frequency greater than 1/100.
Reported diseases fall into the following areas:
ilustration
Neonatal genetic analysis is an alternative that increases the range of heel prick test results. The following comparative graph details the clinical application of the service in comparison to that test:
ilustration

How does it work?

  1. elige tu test genético
    Select desired analysis and a specialist, then you have a video-consultation.
  2. frotis bucal para análisis
    Receive a sample collector kit at home that will be picked up by a courier.
  3. instrucciones de uso
    One of our partner labs makes the analysis.
  4. instrucciones de uso
    Your healthcare professional presents your results via videoconference.
go further

More information

Buy

Information request

Enter the verification code to continue

In compliance with the requirements of REGULATION (EU) 2016 / 679 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 27 april 2016 on the protection of individuals with regard to the processing of personal data and the free movement of such data and repealing directive 95 / 46 / ec (general regulation of data protection), you are informed that Info ...

This site uses both its own cookies and third-party cookies in order to obtain statistical data on the browsing activity of its users. You accept these cookies by continuing to browse the Portal or by clicking ACCEPT You can find information on how to enable/disable browser cookies reading our Cookie Policy

This site uses both its own cookies and third-party cookies (files which are installed on the user’s device and which record browsing information) in order to obtain statistical data on the browsing activity of its users. By clicking ACCEPT or by continuing to browse the Portal, you accept that PROMETUM SPAIN S.L.U. may store and use these cookies. To find out more, please read our Cookie Policy where you can also find information on how to enable/disable browser cookies. ACCEPT